TCL Archive Working Group: Restructure NCI, Improve Review Process, Encourage Independence July 14, 1995
TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
TCL Archive New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science January 8, 1999